These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22230449)

  • 1. Inhibiting angiogenesis in malignant gliomas.
    Chi AS; Wen PY
    Handb Clin Neurol; 2012; 104():279-308. PubMed ID: 22230449
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
    Kepes JJ
    Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-angiogenesis treatment for brain tumors: present and future].
    Takano S; Matsumura A
    No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiangiogenesis: biology and utility in the treatment of gliomas.
    Chamberlain MC
    Expert Rev Neurother; 2008 Oct; 8(10):1419-23. PubMed ID: 18928336
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
    Argyriou AA; Giannopoulou E; Kalofonos HP
    Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model.
    Wu ZP; Gao CW; Wu YG; Zhu QS; Yan Chen ; Xin Liu ; Chuen Liu
    Integr Cancer Ther; 2009 Mar; 8(1):88-92. PubMed ID: 19174507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic approaches to malignant gliomas.
    Soffietti R; Trevisan E; Bertero L; Bosa C; Ruda R
    Curr Cancer Drug Targets; 2012 Mar; 12(3):279-88. PubMed ID: 22229250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis and invasion in malignant gliomas.
    Chi A; Norden AD; Wen PY
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents.
    Perry JR
    Curr Opin Neurol; 2010 Dec; 23(6):592-6. PubMed ID: 20881488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy.
    Rege TA; Fears CY; Gladson CL
    Neuro Oncol; 2005 Apr; 7(2):106-21. PubMed ID: 15831230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.
    Anderson JC; Grammer JR; Wang W; Nabors LB; Henkin J; Stewart JE; Gladson CL
    Cancer Biol Ther; 2007 Mar; 6(3):454-62. PubMed ID: 17384534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon perforation during antiangiogenic therapy for malignant glioma.
    Norden AD; Drappatz J; Ciampa AS; Doherty L; LaFrankie DC; Kesari S; Wen PY
    Neuro Oncol; 2009 Feb; 11(1):92-5. PubMed ID: 18757774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for recurrent malignant glioma in adults.
    Mrugala MM; Kesari S; Ramakrishna N; Wen PY
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):759-82. PubMed ID: 15485312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in glioma: molecular mechanisms and roadblocks to translation.
    Bögler O; Mikkelsen T
    Cancer J; 2003; 9(3):205-13. PubMed ID: 12952305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New agents and new end points for recurrent gliomas.
    Brandes AA; Franceschi E
    J Clin Oncol; 2011 Mar; 29(9):e245-6; author reply e247. PubMed ID: 21282544
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primetime for antiangiogenic therapy.
    Tabatabai G; Stupp R
    Curr Opin Neurol; 2009 Dec; 22(6):639-44. PubMed ID: 19786873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.